Tag Archives: biotech

Trinity Life Sciences Expanding Life Sciences Commercialization Capabilities

Trinity Life Sciences (Trinity) has since grown to comprise a global team of advisors, technical experts, data integrators, and technology innovators. Trinity’s vision is to be the premier global life sciences commercialization partner, empowering clients to deliver life-changing therapies to patients

Ashfield Launches EmerGENE to Support Biotechs’ Commercialization Activities

Ashfield, part of UDG Healthcare plc, has announced the launch of EmerGENE, a global end-to-end cell and gene therapy network approach which promises to support small and midsize biotechs with the commercialization of their discoveries

SCYNEXIS Partnering with Amplity Health to Launch BrexafemmeTM

SCYNEXIS announced that it has partnered with Amplity Health, a leading global contract commercialization organization, to support the anticipated U.S. commercialization of Brexafemme

CareMetx’s Private Equity Investments to Accelerate Company’s Growth

Recently, CareMetx started a new division, OutcomeRx, to focus on holistic solutions for  biotech companies to address the patient, manufacturer, and payer challenges in the evolving Cell and Gene Therapy (CGT) market

Fishawack Health Acquires The Hive Health Group

Fishawack Health is a leading global commercialization partner for the modern life sciences era

Trinity Acquires BluePrint Research Group Strengthening Commercialization Potential

Trinity’s approach is focused on its foundation of three: advisory services, insights & analytics, and technology

CareMetx, LLC’s OutcomeRx Launches a Reinsurance Product for Cell and Gene Therapies

OutcomeRx focuses on engaging with biotech companies to think through, structure, and manage value-based agreements

RareMed Solutions Providing Non-Commercial Dispensing Services for PTC Therapeutics’ EMFLAZA

RareMed Solutions is the nation’s only (pure) rare and devastating disorder patient service provider (PSP)